contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  availableLanguages
  pageUrl
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
      }
      id
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


interim-report-january-march-2024-proprietary-simulators-weak-industrial-segment-strong

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

availableLanguages

pageUrl

imgUrl

description

Surgical Science Sweden is a medical technology company. The company develops VR simulators in surgery. The simulators consist of both hardware and software used in training and personal development by surgeons. The hardware simulates various surgical procedures, with mainly use in peephole surgery and endoscopy. The vision is to strengthen the competence in surgery and create conditions for better treatments. The company is headquartered in Gothenburg.

Surgical Science Sweden

FIRST QUARTER 2024 (JAN – MAR)Net sales amounted to SEK 188.2 (229.1) million, a decrease of 18 percent compared with the corresponding period in the preceding year.License revenue amounted ...

<div class="mfn-body">FIRST QUARTER 2024 (JAN – MAR)Net sales amounted to SEK 188.2 (229.1) million, a decrease of 18 percent compared with the corresponding period in the preceding year.License revenue amounted to SEK 63.2 (70.6) million and accounted for 34 (31) percent of net sales.The gross margin was 66 (69) percent.Operating profit amounted to SEK 26.0 (53.3) million.Net profit amounted to SEK 23.8 (49.8) million, corresponding to earnings per share of SEK 0.47 (0.98).Cash flow from operating activities amounted to SEK 28.5 (60.5) million. As of March 31, 2024, cash and cash equivalents amounted to SEK 659.2 (482.1) million.Gothenburg, Sweden, May 15, 2024 Surgical Science Sweden AB (publ)This report, in its entirety, is available through the attachment or via: <a rel="noopener" href="https://surgicalscience.com/aktien/pressmeddelanden/">https://surgicalscience.com/aktien/pressmeddelanden/</a> <a rel="noopener" href="https://surgicalscience.com/aktien/finansiella-rapporter/">https://surgicalscience.com/aktien/finansiella-rapporter/</a>This is a translation of the Swedish version of the interim report. When in doubt, the Swedish wording prevails.</div><div class="mfn-footer mfn-contacts mfn-641786c7ad88">For further information, please contact:<hr>Gisli Hennermark, CEO Telephone: +46-70-420 83 00 E-mail:&nbsp;<a rel="noopener" href="mailto:gisli.hennermark@surgicalscience.com">gisli.hennermark@surgicalscience.com</a>Anna Ahlberg, CFO Telephone: +46-70-855 38 35 E-mail:&nbsp;<a rel="noopener" href="mailto:anna.ahlberg@surgicalscience.com">anna.ahlberg@surgicalscience.com</a></div><div class="mfn-footer mfn-about mfn-cd84c254f9cb">About Surgical Science Sweden AB (publ)<hr>One of the biggest challenges within healthcare globally is reducing injuries incurred during care. Medical education and training are key, especially as a large part of the training can now be performed outside the operating room. Surgical Science is a world leader in the development of virtual reality simulators for evidence-based training. The simulators enable surgeons and other medical specialists to train and improve their psycho-motor skills and instrument handling before entering the clinical environment. Alongside its own products, Surgical Science works with simulation solutions for medical device companies that develop instruments for clinical use, such as robotic surgery.Surgical Science has approximately 260 employees. The company is headquartered in Gothenburg, Sweden and also has operations in Tel Aviv, Israel, as well as in Stockholm, Sweden and in Seattle and Cleveland, US. Through sales offices in the US and China as well as a global network of distributors, Surgical Science maintains a presence in most markets. Shares in Surgical Science Sweden AB (publ) are traded on Nasdaq First North Growth Market. Certified Adviser is Carnegie Investment Bank AB (publ).</div><div class="mfn-footer mfn-regulatory mfn-regulatory-mar">This information is information that Surgical Science Sweden AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2024-05-15 07:30 CEST.</div><div class="mfn-footer mfn-attachment mfn-attachment-general">Attachments<hr><a rel="noopener" href="https://storage.mfn.se/133bd1b0-5f19-4ff0-80ef-c36e225a77cf/240515-q12024-eng.pdf" class="mfn-primary">240515 Q12024 ENG</a></div>

Interim report January – March 2024: PROPRIETARY SIMULATORS WEAK, INDUSTRIAL SEGMENT STRONG

Pysy ajantasalla Inderesin uutiskirjeillä